Condition
Fluoxetine
Total Trials
4
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (1)
P 4 (1)
Trial Status
Recruiting2
Unknown2
Clinical Trials (4)
Showing 4 of 4 trials
NCT07174947Phase 2Recruiting
SSRI Antidepressant Fluoxetine Improving Immunotherapy Efficacy in Advanced Hepatobiliary Malignancy Patients With Depression and Anxiety
NCT06221722Recruiting
Predicting Treatment Outcomes in Refractory Constipation Through Brain Connectivity Evaluation
NCT04154813Not ApplicableUnknownPrimary
Study on the Optimal Strategy of Chinese Patients With Bulimia Nervosa After Fluoxetine Treatment
NCT01204086Phase 4Unknown
Pharmacogenomics Studies of Antidepressants
Showing all 4 trials